CanSino Biologics Inc.
CASBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $5 | $14 | $36 |
| - Cash | $2 | $2 | $3 | $5 |
| + Debt | $2 | $3 | $3 | $1 |
| Enterprise Value | $8 | $6 | $14 | $32 |
| Revenue | $1 | $0 | $1 | $4 |
| % Growth | 139% | -66.5% | -76% | – |
| Gross Profit | $1 | -$1 | -$0 | $3 |
| % Margin | 70.4% | -253.8% | -18.1% | 69.8% |
| EBITDA | -$0 | -$2 | -$1 | $2 |
| % Margin | -13.3% | -476.8% | -127.9% | 43% |
| Net Income | -$0 | -$1 | -$1 | $2 |
| % Margin | -45.9% | -429.6% | -88.2% | 44.5% |
| EPS Diluted | -1.53 | -6.01 | -3.69 | 7.74 |
| % Growth | 74.5% | -62.9% | -147.7% | – |
| Operating Cash Flow | -$0 | -$1 | -$2 | $2 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$1 | -$2 | -$3 | $1 |